Preinduction cervical ripening: Basis and methods of current practice

Obstetrical and Gynecological Survey

Volumn 57, Issue 10, 2002, Pages 683-692

  Rayburn, William F ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN; PROSTAGLANDIN E2; UTERUS SPASMOLYTIC AGENT;

CESAREAN SECTION; CLINICAL PRACTICE; FEMALE; HOSPITALIZATION; HUMAN; LABOR INDUCTION; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; REVIEW; UTERINE CERVIX DILATATION; UTERINE CERVIX RIPENING;

CERVICAL RIPENING; CERVIX UTERI; CESAREAN SECTION; DINOPROSTONE; FEMALE; HUMANS; LABOR, INDUCED; LENGTH OF STAY; MISOPROSTOL; OXYTOCICS; PREGNANCY; TOCOLYTIC AGENTS;

EID: 0036792318     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-200210000-00022     Document Type: Review

References (53)

1. Zhang J, Yancey MK, Henderson CE. US National trends in labor induction, 1989-1998. J Reprod Med 2002;47:120-4.
2. Beebe L, Rayburn W, Beaty C et al. Indications and rates of induction of labor: A comparison between a university hospital and community hospital. J Reprod Med 2000;45:469-75.
3. Yeast JD, Jones A, Poskin M. Induction of labor and the relationship to cesaren delivery: A review of 7001 consecutive inductions. Am J Obstet Gynecol 1999;180:628-33.
4. Dublin S, Lydon-Rochelle M, Kaplan RC et al. Maternal and neonatal outcomes after induction of labor without an identified indication. Am J Obstet Gynecol 2000;183:986-94.
5. American College of Obstetricians and Gynecologists. Induction of labor ACOG Practice Bulletin no. 10. Washington DC; ACOG, 1999.
6. Gonen O, Rosen DJ, Dolfin Z et al. Induction of labor versus expectant management in macrosomia: A randomized study. Obstet Gynecol 1997;89:913-7.
7. Conway DL, Langer O. Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia versus increased cesarean deliveries. Am J Obstet Gynecol 1998;178:922-5.
8. Friesen C, Miller A, Rayburn W. Influence of fetal macrosomia on intrapartum complications and uterine activity during labor. Am J Perinatol 1995;173:1166-70.
9. Conway DL, Adkins WB, Schroeder B et al. Isolated oligohydramnios in the term pregnancy: Is it a clinical entity? J Maternal Fetal Med 1998;7:197-200.
10. American College of Obstetricians and Gynecologists. Assessment of fetal lung maturity. ACOG Educational Bulletin, Number 230, November 1996.
11. Danforth DN, Veis A, Breen M et al. The effect of pregnancy and labor on the human cervix: changes in collagen, glycoproteins, and glycosaminoglycans. Am J Obstet Gynecol 1974;120:641-5.
12. Bishop EM. Pelvic scoring for elective induction. Obstet Gynecol 1964;24:266-8.
13. Keirse M. Prostaglandin in preinduction cervical ripening: meta-analysis of worldwide clinical experience. J Reprod Med 1993;38:89-94.
14. 2 in pregnancy. Lancet 1981;2:267-72.
15. 2 in the term cervix. J Maternal Fetal Invest 1994;4:137-40.
16. 2 during preinduction cervical ripening. Am J Obstet Gynecol 1991;165:1006-10.
17. Wikland M, Lindblom B, Wiquist N. Myometrial response to prostaglandins during labor. Gynecol Obstet Invest 1984;17:131-6.
18. 2 on the closure time of the ductus arteriosus in term newborns. J Pediatr 1993;122:632-7.
19. Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripeningand induction of labor (Cochrane Review). In: The Cochrane Library, Issue 4, 2001. Oxford Update Software.
20. American College of Obstetricians and Gynecologists. Induction of labor with misoprostol. ACOG, 1999.
21. 22) for induction of labour at term (Cochrane Review). In: The Cochrane Library, Issue 4, 2001. Oxford: Update Software
22. Cervidil. Physician's Desk Reference, 56th ed. Montvale, NJ: Medical Economics, 2002, pp 1369-70.
23. 2 vaginal insert. J Reprod Med 2001;46:599-600.
24. 2 vaginal insert. Experience at a community hospital. J Reprod Med, 1997;43:408-12.
25. Prepidil, Physician's Desk Reference, 56th ed. Montvale, NJ: Medical Economics, 2002, pp 2851-3.
26. 2 therapy: Tocolytic treatment in 181 cases. Am J Obstet Gynecol 1991;133:794-9.
27. Blumenthal PD, Ramanauskas R. Randomized trial of Dilipan and Laminaria as cervical ripening agents before induction of labor. Obstet Gynecol 1991;75:365-71.
28. Atad J, Bernstein J, Calderon I et al. Nonpharmaceutical ripening of the unfavorable cervix and induction of labor by novel double balloon device. Obstet Gynecol 1991;77:146-51.
29. Boulvain M, Kelly A, Lohse C et al. Mechanical methods for induction of labour (Cochrane Review). In: The Cochrane Library, Issue 4, 2001. Oxford: Updated Software.
30. Frydman R, Lelaidier C, Baton-Saint-Mleux C et al. Labor induction in women at term with mifepristone (RU 486): A double-blind, randomized, placebo-controlled study. Obstet Gynecol 1992;80:972-7.
31. Giacalone P, Targosz V, Laffargue F et al. Cervical ripening with mifepristone before labor induction: A randomized study. Obstet Gynecol 1998;92:487-92.
32. Mitchell MD, Flint APF, Bibby J et al. Rapid increases in plasma prostaglandin concentrations after vaginal examination and amniotomy. Br Med J 1977;2:1183-7.
33. McColgin SW, Hampton HL, McCaul JF et al. Stripping membranes at term: Can it safely reduce the incidence of post-term pregnancies? Obstet Gynecol 1990;76:678-83.
34. Nuutila M, Halmesmaki E, Hiilesmaa V et al. Women's anticipations of and experiences with induction of labor. Acta Obstet Gynecol Scand 1999;78:704-9.
35. Crowley P. Interventions for preventing or improving the outcome of delivery at or beyond term (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Updated Software.
36. 2 gel for cervical ripening and induction of labor: A critical analysis. Am J Obstet Gynecol 1989;160:529-34.
37. Kiss H, Ahner R, Hohlagschandtner M et al. Fetal fibrinectin as a predictor of term labor: A literature review. Acta Obstet Gynecol Scand 2000;79:3-7.
38. American College of Obstetricians and Gynecologists. Vaginal birth after previous cesarean delivery. ACOG Practice Bulletin no. 2. Washington DG: ACOG, 1998.
39. Zelop CM, Shipp TD, Repke JT et al. Uterine rupture during induced or augmented labor in gravid women with one prior cesarean delivery. Am J Obstet Gynecol 1999;181:882-6.
40. Ravasia DJ, Woods SL, Pollard JK. Uterine rupture during induced trial of labor among women with previous cesarean delivery. Am J Obstet Gynecol 2000;183:1176-9.
41. Wing DA, Lovett K, Paul RH. Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstet Gynecol 1998;91:828-30.
42. Lydon-Rochelle M, Holt V, Easterling T et al. Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med 2001;345:3-8.
43. 2 vaginal insert for cervical ripening. J Reprod Med 1999;94:250-4.
44. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. A clinical trial of induction of labor versus expectant management in post-term pregnancy. Am J Obstet Gynecol 1994;170:716-23.
45. Novakov A, Segedi D, Milasinovic L et al. Induction of labor by endocervical application of prostaglandins and intravenous infusion of oxytocin in postterm pregnancy. Med Preg 1998;51:419-26.
46. 2 as an intracervical gel, using oxytocin immediately versus a sustained-release vaginal insert for induction of labor. Am J Obstet Gynecol 1998;179:1241-7.
47. Wing DA, Paul RH. Induction of labor with misoprostol for premature rupture of membranes beyond 36 weeks' gestation. Am J Obstet Gynecol 1998;179:94-9.
48. Sanchez-Ramos L, Chen AH, Kaunitz AM et al. Labor induction with intravaginal misoprostol in term premature rupture of membranes: A randomized study. Obstet Gynecol 1997;89:909-12.
49. 2 gel versus misoprostol for cervical ripening in patients with premature rupture of membranes after 34 weeks. Obstet Gynecol 2002;99:206-10.
50. 2 suppositories. Physicians' Desk Reference, 56th ed. Montvale, NJ: Medical Economics, 2002, pp. 2852-4.
51. Bugalho A, Bique C, Machungo F et al. Induction of labor with intravaginal misoprostol in intrauterine fetal death. Am J Obstet Gynecol 1994;171:538-541.
52. 2. J Reprod Med 1997;42:497-500.
53. Fronterhouse W, Christensen FC, Rayburn LA et al. Mandated preterm delivery: Its prevalence and impact at a tertiary referral center. J Maternal Fetal Med 2001;10:1-4.